PSA screening – Talking About Men's Health

When a Leader’s Diagnosis Becomes a National Wake-Up Call: Prostate Cancer, Awareness, and the Urgent Need for Change

May 28, 2025May 27, 2025MHN EditorAdvocacy, Aging, Disparities, Editorials, Family, Fertility, Health, Legislative, Lifestyle, New Again, Other Cancers, Others, Policy, Prostate, Public Policy, Regulatory, Research and Science, Testicular, Well-beingLeave a comment

Former President Joe Biden’s stage 4 prostate cancer diagnosis underscores a national failure in men’s health and preventive care. Men’s Health Network is calling for urgent reform to PSA screening guidelines, improved prostate cancer awareness, and expanded support for men’s healthcare—especially for those over age 70. Prostate cancer is highly treatable when detected early, making timely prostate screenings critical. This moment is a wake-up call to prioritize men’s health policy, close the Lifespan Gender Gap, and increase health education for men.Continue reading

Understanding the New PSA Testing Guidelines

July 18, 2013December 27, 2013David Samadi, MD - Medical ContributorHealth, Prostate

Recently the American Urological Association (AUA) announced new guidelines for prostate specific antigen (PSA) testing. These guidelines were designed to help urologists, and ultimately patients, reduce prostate cancer mortality by making informed screening decisions. These recommendations were based on comprehensive literature reviews and the strength of the existing evidence.

Know Your Prostate: Top Surgeon Offers Free Prostate Cancer Screenings

February 14, 2013January 30, 2014Health, Prostate

Dr. David Samadi, a world-renowned prostate cancer surgeon is all set to conduct free prostate cancer screenings at the Chian Federation, 4401 Broadway in Astoria, New York 11103 on Saturday, February 16 2013. Men who attend this screening event will receive Prostate-specific antigen (PSA) blood tests and/or digital rectal exams (DRE) at no charge between...

Dr. David Samadi Speaks On The Pros And Cons of PSA Screening

September 25, 2012September 26, 2012David Samadi, MD - Medical ContributorHealth, Prostate

The controversial decision of the United States Preventative Services Task Force (USPSTF) to recommend against screening men for prostate cancer has prompted a healthy debate regarding the utility of the early detection of this cancer. Despite our best efforts for early detection, prostate cancer remains the second leading cancer cause of death in men, killing...Continue reading

An Informed Decision

March 22, 2010March 7, 2012Ramon P. Llamas, MPH, CHESPolicy, Prostate, Public Policy

Richard J. Ablin, research professor of immunobiology at the University of Arizona College of Medicine, has been studying prostate cancer for over 40 years. After discovering the Prostate-Specific Antigen (PSA), an enzyme made by the prostate, and subsequent approval by the Food and Drug Administration in 1994, the PSA test is the most commonly used...